Two Conditions, Two Mechanisms, Two Treatments

Confusing fibromyalgia with myofascial pain is one of the most common diagnostic errors in clinical practice — and the consequences for treatment are serious. Patients with pure myofascial pain receive a diagnosis of fibromyalgia and are treated with central modulators (pregabalin, duloxetine) instead of needling. Patients with fibromyalgia undergo aggressive needling that exacerbates their symptoms. The distinction is not academic — it is therapeutically decisive.

Myofascial pain is a peripheral condition: the primary problem lies in the muscle (trigger points — nodules of involuntary contraction). Fibromyalgia is a condition of central sensitization: the primary problem lies in the central nervous system (generalized amplification of nociceptive processing). Although they can coexist in the same patient, their pathophysiology and treatments are radically different.

85%
OF PATIENTS WITH FIBROMYALGIA
have concomitant myofascial trigger points
30–40%
OF FIBROMYALGIA DIAGNOSES
may be reclassified as regional myofascial pain
2x
DIFFERENCE IN NEEDLING INTENSITY
required between fibromyalgia (gentle) and myofascial (vigorous)
70%
IMPROVEMENT IN PURE MYOFASCIAL PAIN
with trigger point needling over 4-6 sessions

Diagnostic and Therapeutic Comparison

The table below summarizes the fundamental differences between the two conditions — from mechanism to therapeutic approach. This distinction should guide the entire treatment strategy with medical acupuncture.

FIBROMYALGIA VS. MYOFASCIAL PAIN: RADICAL TREATMENT DIFFERENCES

ASPECTFIBROMYALGIAPURE MYOFASCIAL PAIN
Central mechanismCentral sensitization — generalized amplification of nociceptive processing in the CNSPeripheral dysfunction — myofascial trigger points with predictable referred pain
Type of needlingGENTLE — superficial needling, low stimulation, few points per session (4-8 needles)VIGOROUS — deep needling that actively seeks a twitch response, multiple points per session (10-20 needles)
ElectroacupunctureLow frequency (2 Hz), low intensity — focus on central modulation via endorphinsVariable frequency (2-100 Hz), moderate-to-high intensity — focus on segmental inhibition and trigger-point deactivation
Expected therapeutic responseGradual (8-12 weeks), 30-40% pain improvement. Focus on function and sleep qualityRapid (1-4 sessions), 50-80% improvement in regional pain. Trigger-point resolution is a measurable objective
Risk of exacerbationHIGH if needling is intense — a patient with central sensitization may flare for 2-5 daysLOW — post-needling soreness is mild and self-limited (12-48h). Flare-ups are rare with appropriate technique

Fibromyalgia: The Problem Is in the Brain, Not the Muscle

Fibromyalgia is a syndrome of central sensitization — a state in which the central nervous system amplifies nociceptive signals, turning normal or mild stimuli into intense pain. Functional neuroimaging published in Rheumatology demonstrates hyperactivity of the insular córtex, anterior cingulate córtex, and insula in response to stimuli that healthy individuals do not perceive as painful. Documented findings include reduced inhibitory neurotransmitters (GABA, serotonin, norepinephrine) and elevated excitatory neurotransmitters (glutamate, substance P) in cerebrospinal fluid.

In fibromyalgia, the trigger points that frequently coexist are a consequence — not a cause — of central sensitization. The increase in baseline muscle tone mediated centrally facilitates the formation of secondary trigger points. For this reason, treatment that targets only trigger points without modulating the central system will yield limited and transient results.

Pathophysiology of Fibromyalgia — Central Sensitization

  1. Dysfunction of central inhibitory systems

    Reduced serotonin, norepinephrine, and GABA in the brainstem and spinal cord. Descending pain-modulation pathways weaken — the natural brake on nociception fails.

  2. Increase in excitatory neurotransmitters

    Elevated substance P and glutamate in cerebrospinal fluid. Wide dynamic range (WDR) neurons in the dorsal horn hypersensitize — they respond to light tactile stimuli as if painful (allodynia).

  3. Cortical amplification of pain

    Hyperactive insular and anterior cingulate córtex. Each nociceptive signal is amplified and processed with an exacerbated affective-emotional component — pain feels more intense and more distressing.

  4. Associated symptoms (central comorbidities)

    Chronic fatigue, non-restorative sleep, cognitive fog (fibro fog), sensitivity to stimuli (light, sound, temperature). All mediated by central dysfunction — not the muscle.

Pure Myofascial Pain: The Problem Is in the Muscle

Myofascial pain syndrome is a peripheral condition in which trigger points — nodules of involuntary contraction within taut muscle bands — generate predictable referred pain, restricted range of motion, and motor dysfunction. The mechanism is local: focal ischemia at the motor endplate, excessive acetylcholine release, sustained sarcomere shortening, and sensitization of muscle nociceptors.

In pure myofascial pain, the central nervous system is intact — no generalized central sensitization, no diffuse allodynia, no chronic fatigue, no cognitive fog. Trigger points are the primary cause of pain, and direct treatment (needling that elicits a twitch response) produces rapid and durable results. The difference in response speed between the two conditions is one of the most useful diagnostic markers in clinical practice.

Needling Protocol: Practical Differences

The differences in needling protocol between fibromyalgia and myofascial pain are só significant that using the wrong protocol can be worse than not treating at all. The medical acupuncturist must tune each parameter — needle count, depth, stimulation intensity, electroacupuncture frequency, and treatment cadence — to the predominant mechanism.

NEEDLING PARAMETERS: FIBROMYALGIA VS. MYOFASCIAL PAIN

PARAMETERFIBROMYALGIAPURE MYOFASCIAL PAIN
Number of needles per session4–8 needles (less is more)10–20 needles (per identified trigger points)
Depth of insertionSuperficial to intermediate (1–2 cm)Deep — into the taut band (2–5 cm, depending on muscle)
Stimulation techniqueMinimal — insert and leave in situ for 20–30 minActive — pistoning with search for twitch response
Electroacupuncture2 Hz, minimum comfortable intensity2–100 Hz alternating, moderate intensity
Session frequency1x/week (never 2x, due to risk of exacerbation)2x/week (accelerates trigger point deactivation)
Systemic pointsGV20, HT7, PC6, LR3 (central modulation and sleep)Segmental by region — focus on the affected muscle
Time to significant improvement8–12 weeks2–4 weeks

When the Two Conditions Coexist

The most challenging clinical situation is the patient who has fibromyalgia with concomitant trigger points — which occurs in up to 85% of cases. In these patients, both components must be treated sequentially: first modulate the central sensitization (to reduce hyperreactivity) and only then address the peripheral trigger points with progressively more intense stimulation.

  • Phase 1 (weeks 1–4): Gentle systemic acupuncture — focus on central modulation. Points GV20, HT7, PC6, LR3, SP6. Electroacupuncture at 2 Hz with minimum intensity. Goal: improve sleep and reduce hyperreactivity
  • Phase 2 (weeks 5–8): Gradually introduce trigger-point needling — start with the most symptomatic, using gentle technique (no aggressive pistoning). Watch for post-session flare-ups lasting more than 48h
  • Phase 3 (weeks 9–12): If tolerated, progress to more vigorous needling of the remaining trigger points. Combine central modulation with peripheral deactivation in the same session
  • Monitoring: Keep a pain diary (NRS scale) and a sleep diary. If trigger-point needling worsens diffuse pain for more than 48h, scale back to a gentler technique in the next session
  • Concurrent pharmacotherapy: Fibromyalgia patients frequently take pregabalin or duloxetine. Acupuncture is adjunctive — do not discontinue without guidance from the prescribing physician

Myths and Facts

Myth vs. Fact

MYTH

Fibromyalgia and myofascial pain are the same thing

FACT

They are pathophysiologically distinct conditions: fibromyalgia is central sensitization (a CNS problem), myofascial pain is peripheral dysfunction (trigger points in muscle). They can coexist, but treatment is radically different.

MYTH

The more vigorous the needling, the better the result in any painful condition

FACT

In fibromyalgia, vigorous needling can flare pain for 2-5 days by hyperstimulating an already hypersensitive system. Less is more in fibromyalgia; in myofascial pain, actively eliciting a twitch response is essential.

MYTH

If a patient has generalized pain, it is fibromyalgia

FACT

Myofascial pain can be generalized when multiple trigger points are active across different regions. The difference lies in quality (discrete points vs. diffuse hypersensitivity), associated symptoms (sleep, fatigue, cognition), and pain pressure threshold.

Frequently Asked Questions

FREQUENTLY ASKED QUESTIONS · 05

Frequently Asked Questions

If performed inappropriately (very intense needling, many needles, vigorous stimulation), yes. That is why the medical acupuncturist must recognize fibromyalgia and adapt the protocol: fewer needles, less stimulation, weekly cadence. With appropriate technique, acupuncture improves pain and sleep in fibromyalgia.

Evaluation by a chronic-pain specialist or medical acupuncturist is essential. Signs suggesting myofascial pain: localized or regional pain, pressure points that reproduce the pain, rapid improvement with needling. Signs of fibromyalgia: diffuse generalized pain, chronic fatigue, non-restorative sleep, cognitive fog, hypersensitivity to multiple stimuli.

Diagnosis is essentially clinical. No laboratory or imaging test confirms fibromyalgia or myofascial pain. Tests may be ordered to rule out other conditions (hypothyroidism, rheumatoid arthritis, vitamin D deficiency). The algometer (pressure gauge) is useful for quantifying pain pressure threshold.

Yes — and it is very common (up to 85% of fibromyalgia patients have concomitant trigger points). Treatment in this case is sequential: first modulate central sensitization with gentle systemic acupuncture, then progressively address the trigger points.

Pure myofascial pain: favorable prognosis — in clinical series, 70-80% of patients report significant relief within 4-6 weeks, with sustained improvement in many cases. Fibromyalgia: gradual relief within 8-12 weeks (on the order of 30-40% pain reduction), with additional benefits in sleep and function. Fibromyalgia is a chronic condition that usually requires long-term maintenance; individual responses vary.